Real-time · AI · Cross-signal
Discover the power of real-time signals plus AI
Every contract, funding round, exec hire, and M&A move on Multiply Labs, Inc. — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
Collaboration Between Multiply Labs and Legend Biotech for Automating Cell Therapy Manufacturing
Sep 24, 2024•over 1 year ago
Contract Type
partnership
Description
Multiply Labs has announced a collaboration with Legend Biotech Corporation to focus on automating cell therapy manufacturing. Legend Biotech will evaluate Multiply Labs' robotic technologies and gain priority access to automated systems. This collaboration aims to enable a more rapid and seamless adoption of robotic technology in the cell therapy space.
Related People
Suggested for you
Sign in to view contact details
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months